Dry Eye Syndrome Clinical Trials

153 clinical trials for Dry Eye Syndrome across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA) — RECRUITING · PHASE1
• Study of Proteomic Factors in Patients With Severe Dry Eye Syndrome Treated With Autologous Serum Eye Drops. — RECRUITING · NA
• A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK — RECRUITING · PHASE4
• Evaluation of a Novel Ocular Lubricating Eye Drop — RECRUITING · NA
• Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface — RECRUITING
• Autologous Serum Eye Drops in Dry Eye Syndrome — RECRUITING · NA
• Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS) — RECRUITING · PHASE2
• Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome — RECRUITING
• RANDOMIZED CONTROLLED CLINICAL STUDY ON THE EFFICACY AND TOLERABILITY OF 0.4% HYALURONIC ACID HYPOTONIC EYE DROPS (IALUREX) VS. HYDROXYPROPYL-GUAR EYE DROPS (SYSTANE) IN THE TREATMENT OF DRY EYE SYNDROME — COMPLETED · PHASE4
• Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease — COMPLETED · NA
• Impact of Filtration on Autologous Serum Eye Drops — COMPLETED · NA
• Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome — WITHDRAWN · NA
• Safety and Efficacy of BRM421 for Dry Eye Syndrome — COMPLETED · PHASE2
• Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment — COMPLETED · PHASE2
• This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye — NOT_YET_RECRUITING · PHASE4
• Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy — TERMINATED · NA
• Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome. — COMPLETED · NA
• Safety and Efficacy of Kelulut Honey Eyedrops in Dry Eye Disease — NOT_YET_RECRUITING · NA
• Potential Role of Ocular Surface Microbiome in Dry Eye: Microbial Interactions and Symptom Alleviation — COMPLETED · NA
• The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability — COMPLETED · NA
• A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease — COMPLETED · PHASE1
• Dietary Supplementation on Tear Secretion and Inflammation in DES — COMPLETED · NA
• Comparing Effect of Hylorunic Acid and Lipid-coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP — ACTIVE_NOT_RECRUITING · NA
• Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DES — ACTIVE_NOT_RECRUITING · NA
• Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop — COMPLETED · NA
• Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye — COMPLETED · NA
• A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease — COMPLETED · PHASE2
• Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye — COMPLETED · NA
• Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye — COMPLETED · NA
• A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants — COMPLETED · PHASE3
• Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15% — OTHER · NA
• Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome — NOT_YET_RECRUITING
• A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye — COMPLETED · PHASE2
• Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye — COMPLETED · PHASE2
• Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome — COMPLETED
• Effect of an Educational Program on Health-related Outcomes of Patients With Dry Eye Syndrome — COMPLETED · NA
• Safety and Efficacy of TOP1630 for Dry Eye Syndrome — COMPLETED · PHASE2
• VGH-DESJS-1 in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome and Sjögren's Syndrome — COMPLETED · NA
• Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops — OTHER
• Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease — COMPLETED · PHASE1
• Probiotic in Dry Eye Syndromes — COMPLETED · PHASE2
• Objective Measurement With TCM Pattern for AIDDES — OTHER
• To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome — OTHER · NA
• Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank — NOT_YET_RECRUITING
• To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance — TERMINATED · NA
• Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction — COMPLETED · NA
• Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye Syndrome — COMPLETED
• Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome. — COMPLETED · PHASE2
• Efficacy, Safety of T2769 in Dry Eye Disease — COMPLETED · NA
• Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients — OTHER · PHASE3

Refine this search